Sustained Release Excipients Market Size, Share & Trends Report

Sustained Release Excipients Market (2023 - 2030) Size, Share & Trends Analysis Report By Route Of Administration (Oral, Transdermal), By Technology (Transdermal, Implants), By Product (Gelatin, Sugars), By Region, And Segment Forecasts

Market Segmentation

Sustained Release Excipients Market Product Outlook (Revenue, USD Million, 2018 - 2030)
- Gelatin
- Polymers
- Minerals
- Sugars
- Alcohol
- Chitosan
Sustained Release Excipients Market Technology Outlook (Revenue, USD Million; 2018 - 2030)
- Targeted Delivery
- Micro Encapsulation
- Wurster Technique
- Transdermal
- Implants
- Coacervation
- Others
Sustained Release Excipients Market Route of Administration Outlook (Revenue, USD Million; 2018 - 2030)
- Oral
- Intramuscular
- Subcutaneous
- Transdermal
- Vaginal
- Ophthalmic
- Intravenous
- Others
Sustained Release Excipients Market Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Gelatin
    - Polymers
    - Minerals
    - Sugars
    - Alcohol
    - Chitosan
  - North America Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Targeted Delivery
    - Micro Encapsulation
    - Wurster Technique
    - Transdermal
    - Implants
    - Coacervation
    - Others
  - North America Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
    - Oral
    - Intramuscular
    - Subcutaneous
    - Transdermal
    - Vaginal
    - Ophthalmic
    - Intravenous
    - Others
  - U.S.
    - U.S. Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - U.S. Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - U.S. Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Canada
    - Canada Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Canada Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Canada Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
- Europe
  - Europe Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Gelatin
    - Polymers
    - Minerals
    - Sugars
    - Alcohol
    - Chitosan
  - Europe Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Targeted Delivery
    - Micro Encapsulation
    - Wurster Technique
    - Transdermal
    - Implants
    - Coacervation
    - Others
  - Europe Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
    - Oral
    - Intramuscular
    - Subcutaneous
    - Transdermal
    - Vaginal
    - Ophthalmic
    - Intravenous
    - Others
  - UK
    - UK Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - UK Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - UK Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Germany
    - Germany Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Germany Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Germany Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - France
    - France Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - France Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - France Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Spain
    - Spain Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Spain Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Spain Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Italy
    - Italy Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Italy Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Italy Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Denmark
    - Denmark Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Denmark Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Denmark Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Norway
    - Norway Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Norway Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Norway Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Sweden
    - Sweden Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Sweden Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Sweden Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
- Asia Pacifc
  - Asia Pacifc Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Gelatin
    - Polymers
    - Minerals
    - Sugars
    - Alcohol
    - Chitosan
  - Asia Pacifc Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Targeted Delivery
    - Micro Encapsulation
    - Wurster Technique
    - Transdermal
    - Implants
    - Coacervation
    - Others
  - Asia Pacifc Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
    - Oral
    - Intramuscular
    - Subcutaneous
    - Transdermal
    - Vaginal
    - Ophthalmic
    - Intravenous
    - Others
  - Japan
    - Japan Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Japan Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Japan Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - China
    - China Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - China Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - China Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - India
    - India Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - India Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - India Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - South Korea
    - South Korea Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - South Korea Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - South Korea Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Australia
    - Australia Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Australia Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Australia Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Thailand
    - Thailand Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Thailand Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Thailand Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
- Latin America
  - Latin America Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Gelatin
    - Polymers
    - Minerals
    - Sugars
    - Alcohol
    - Chitosan
  - Latin America Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Targeted Delivery
    - Micro Encapsulation
    - Wurster Technique
    - Transdermal
    - Implants
    - Coacervation
    - Others
  - Latin America Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
    - Oral
    - Intramuscular
    - Subcutaneous
    - Transdermal
    - Vaginal
    - Ophthalmic
    - Intravenous
    - Others
  - Brazil
    - Brazil Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Brazil Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Brazil Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Mexico
    - Mexico Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Mexico Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Mexico Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Argentina
    - Argentina Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Argentina Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Argentina Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
- MEA
  - MEA Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Gelatin
    - Polymers
    - Minerals
    - Sugars
    - Alcohol
    - Chitosan
  - MEA Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Targeted Delivery
    - Micro Encapsulation
    - Wurster Technique
    - Transdermal
    - Implants
    - Coacervation
    - Others
  - MEA Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
    - Oral
    - Intramuscular
    - Subcutaneous
    - Transdermal
    - Vaginal
    - Ophthalmic
    - Intravenous
    - Others
  - South Africa
    - South Africa Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - South Africa Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - South Africa Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Saudi Arabia
    - Saudi Arabia Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Saudi Arabia Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Saudi Arabia Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - UAE
    - UAE Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - UAE Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - UAE Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others
  - Kuwait
    - Kuwait Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Gelatin
      - Polymers
      - Minerals
      - Sugars
      - Alcohol
      - Chitosan
    - Kuwait Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Targeted Delivery
      - Micro Encapsulation
      - Wurster Technique
      - Transdermal
      - Implants
      - Coacervation
      - Others
    - Kuwait Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
      - Oral
      - Intramuscular
      - Subcutaneous
      - Transdermal
      - Vaginal
      - Ophthalmic
      - Intravenous
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments